Industry News
Biotechnology Industry News
Visus, with one drug chasing AbbVie, inks deals to grow pipeline
Visus, with one drug chasing AbbVie, inks deals to grow pipeline ntaylor Thu, 08/19/2021 - 08:24
Biotech co-founder settles accusations of faked research data
Biotech co-founder settles accusations of faked research data ntaylor Thu, 08/19/2021 - 07:45
CRISPR pioneer Feng Zhang’s latest work delivers mRNA, gene therapy with a human protein
CRISPR pioneer Feng Zhang's latest work delivers mRNA, gene therapy with a human protein aliu Wed, 08/18/2021 - 11:15
The CHAMP? Ranok raises $40M to show it can knockout other protein degrader technologies
The CHAMP? Ranok raises $40M to show it can knockout other protein degrader technologies ntaylor Wed, 08/18/2021 - 08:12
Vigil bags $90M to take ex-Amgen assets on path from rare diseases to Alzheimer’s
Vigil bags $90M to take ex-Amgen assets on path from rare diseases to Alzheimer's ntaylor Wed, 08/18/2021 - 03:52
Attacking Alzheimer’s by protecting synapses from amyloid beta
Attacking Alzheimer's by protecting synapses from amyloid beta klahucik Tue, 08/17/2021 - 15:59
Lilly, with Alzheimer’s in its crosshairs, forms new neuroscience unit, unifies oncology under Loxo exec
Lilly, with Alzheimer's in its crosshairs, forms new neuroscience unit, unifies oncology under Loxo exec ntaylor Tue, 08/17/2021 - 07:48
Going big: Bain reels in $1.9B for more mammoth biotech bets
Going big: Bain reels in $1.9B for more mammoth biotech bets ntaylor Tue, 08/17/2021 - 06:02
The 7-year itch? Boehringer culls $600M cancer pact with CureVac, heaping more woe to the biotech
The 7-year itch? Boehringer culls $600M cancer pact with CureVac, heaping more woe to the biotech badams Mon, 08/16/2021 - 10:49
Novartis-backed Penn study proposes boosting CAR-T responses in CLL by waking up ‘war weary’ T cells
Novartis-backed Penn study proposes boosting CAR-T responses in CLL by waking up 'war weary' T cells arlene.weintraub Mon, 08/16/2021 - 09:53
FDA lifts clinical hold on Rocket gene therapy trial, creating launchpad for start of pediatric dosing
FDA lifts clinical hold on Rocket gene therapy trial, creating launchpad for start of pediatric dosing ntaylor Mon, 08/16/2021 - 08:04
Lilly, swinging at the king, shows Dupixent rival works in phase 3, but wait for key figures goes on
Lilly, swinging at the king, shows Dupixent rival works in phase 3, but wait for key figures goes on ntaylor Mon, 08/16/2021 - 06:12
Zombie biotech Sesen Bio’s resurrection plans limping again as FDA rejects bladder cancer drug
Zombie biotech Sesen Bio's resurrection plans limping again as FDA rejects bladder cancer drug badams Mon, 08/16/2021 - 04:41
PureTech Health, having built out internal pipeline, raids Freeline for CMO to oversee clinical trials
PureTech Health, having built out internal pipeline, raids Freeline for CMO to oversee clinical trials ntaylor Fri, 08/13/2021 - 08:07
Ipsen pulls FDA rare disease filing, dealing yet another blow to $1B bet on rare disease drug
Ipsen pulls FDA rare disease filing, dealing yet another blow to $1B bet on rare disease drug ntaylor Fri, 08/13/2021 - 06:00
Insights into the origin of esophageal cancer could boost early detection efforts
Insights into the origin of esophageal cancer could boost early detection efforts arlene.weintraub Thu, 08/12/2021 - 12:22
Merck NK cell ally Artiva splashes out on new digs in San Diego
Merck NK cell ally Artiva splashes out on new digs in San Diego ntaylor Thu, 08/12/2021 - 08:59
Leading longevity researcher accused of sexual harassment
Leading longevity researcher accused of sexual harassment ntaylor Thu, 08/12/2021 - 08:54
Aprea gets 2nd clinical hold in a week, this time for lymphoid malignancy study
Aprea gets 2nd clinical hold in a week, this time for lymphoid malignancy study badams Thu, 08/12/2021 - 08:38
Debut Biotech makes its entrance with a $22M series A for cell-free biomanufacturing facility
Debut Biotech makes its entrance with a $22M series A for cell-free biomanufacturing facility klahucik Wed, 08/11/2021 - 12:48